Similar articles

• Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma.

  Philip T, Guglielmi C, Hagenbeek A, Somers R, Van der Lelie H, Bron D, Sonneveld P, Gisselbrecht C, Cahn JY, Harousseau JL, et al. Philip T, et al. N Engl J Med. 1995 Dec 7;333(23):1540-5. doi: 10.1056/NEJM199512073332305. N Engl J Med. 1995. PMID: 7477169 Clinical Trial.
• Autologous bone marrow transplantation in relapsed non-Hodgkin's lymphoma.

  Koehne CH, Daniel P. Koehne CH, et al. N Engl J Med. 1996 Apr 11;334(15):990-1; author reply 991-2. N Engl J Med. 1996. PMID: 8596609 No abstract available.
• The treatment of relapsed or refractory intermediate grade non-Hodgkin's lymphoma with autologous bone marrow transplantation followed by cyclosporine and interferon.

  Gryn J, Johnson E, Goldman N, Devereux L, Grana G, Hageboutros A, Fernandez E, Constantinou C, Harrer W, Viner E, Goldberg J. Gryn J, et al. Bone Marrow Transplant. 1997 Feb;19(3):221-6. doi: 10.1038/sj.bmt.1700646. Bone Marrow Transplant. 1997. PMID: 9028549
• [Salvage treatments in non-Hodgkin's lymphoma. I].

  Torello E, Koziner B. Torello E, et al. Sangre (Barc). 1993 Feb;38(1):37-45. Sangre (Barc). 1993. PMID: 8470034 Review. Spanish. No abstract available.
• Treatment of relapses in aggressive non Hodgkin's lymphoma.

  Bosly A. Bosly A. Bull Cancer. 2004 Jul-Aug;91(7-8):E261-73. Bull Cancer. 2004. PMID: 15381464 Review.